En
En
Fr
Fr
De
De
It
It
Es
Es
Cn
Cn
16 YEARS OF INTERNATIONAL CLINICAL EXPERIENCE IN TRANSPLANTATION OF HUMAN EMBRYONIC/FETAL STEM CELLS
THE WORLDS LARGEST CLINICAL EXPERIENCE IN EMBRYONIC STEM CELL TRANSPLANTATION FOR VARIOUS DISEASES AND CONDITIONS.

Home
About EmCell
EmCell Therapy
Our Experience
List of Diseases:
Oncology
Diabetes Mellitus
Nervous System
Aging Problems
Immune Deficiency
Endoscopic Treatment of Liver Diseases
Investment Projects
Clinical Trials
Congresses and Conferences
Video and other materials
Mail Center

Publications

18. Treatment of cytostatic agranulocytosis in patients with leukemia by human embryonic liver hemopoietic cells

Smikodoub Alexander, Tretyak Nataliya, Snigyr Nataliya
Cell Therapy Clinic of National Medical University and Embryonic Tissue Center "EmCell"


Cytostatic agranulocytosis and concomitant infections are the often complications of intense 'e polychemotherapy in patients with acute leukosis. Human embryonic hemopoietic cells were used in a complex treatment of cytostatic agranulocytosis in 11 patients.

Cell suspensions, prepared each from one embryo (gestation terms from 6 to 12 weeks) cryopreserved with dimethylsulfoxid, were used. The material was tested on CFU-GM, CFU-GEMM, CD34, and underwent the viral and bacteriological control. The embryonic cells transplantations were performed intravenous drop-wise once or twice.

11 patients with cytostatic agranulocytosis were under observation. Hemopoietic cells were administered to 6 patients for the infection progress prophylaxis. At the trans- plantation moment 5 patients had the following complications: 1 - pneumonia, 1 - sepsis, 1 - angina, mucositis, 3 patients - fever without an educed infection focus.

During 3 days after the transplantation a positive dynamics was observed among all the patients with developed infectious complications: general state improved, intoxi- cation syndrome reduced, body temperature normalized (temperature of the patient with sepsis lowered to subfebrile). There were no infectious complications noted among the patients, who were administered human embryonic hemopoietic cells preventive.

Positive dynamics of peripheral blood parameters corresponded with positive dy- namics of blood clinical picture. At the moment of transplantation the leukocytes number was 0.96+0.17, granulocytes number 145.46+53.84. By the 5th day after transplantation, the leukocytes number was 3.44+2.05, granulocytes number - 203 5.69+ 1026.98. The sta- tistically significant rise of leukocytes number (p<0.05) was achieved by the second week after the transplantation (8-11 day).

Concomitant thrombocytopenia (50.7+11.37) was observed in 9 patients with agranulocytosis, 5 patients were observed for the hemorrhage syndrome signs such as dotty hemorrhage eruption, nasal bleedings. After the administration of hemopoietic cells positive dynamics of thrombocytes was observed. By the 7th day after transplantation thrombocytes number was 186.55+96.35, then more (p<0.05 by the 2 week).

Hemopoietic embryonic suspensions administration enabled to reconstitute hemo- poiesis of the patients, reduce the intoxication and carry on due chemotherapy according to the protocol.


Smikodoub Alexander, Tretyak Nataliya, Snigyr Nataliya Treatment of cytostatic agranulocytosis in patients with leukemia by human embryonic liver hemopoietic cells. Society for Minimally Invasive Therapy Ninth Annual International Meeting 14-16 July 1997, Kyoto, Japan. Minimally Invasive Therapy. 1997, v.5, s.1, p.37.



News
2008-09-25
Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and

Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and Aesthetic Medicine held in Dusseldorf, Germany on September 11-14, 2008 as ...
  Other news
 
Publications

25. Application Of Embryonic Cell Suspensions In Patients With Solid Tumors Before Initiation Of Radical Treatment

Smikodub O.
Cell Therapy Clinic of National Medical University and Embryonic Tissues Center EmCell

Patients with solid tumors and complications that made initiations of anti-cancer treatment impossible, were ...
  Other publications
 
Patents

Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune ...
   
 
Copyright © 1999-2008 EmCell.com